be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Sven Zimmermann Joins MetrioPharm Management as CFO
MetrioPharm AG, a pharmaceutical develop...
Lycored Launches Video to Support Study Findings
Lycored, industry leaders in cultivating we...
Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019, 24-25 September, Gdańsk (Poland)

All articles

Filters:

Show search box

2015-08-12

Mutations in a cell line stops stem-cell trial to cure blindness

Mutations in a cell line stops stem-cell trial to cure blindness

Induced pluripotent stem cells (iPSC) turned into specialized retinal cells were meant to cure the damage caused by age-related macular degeneration leading to blindness. The trial was halted due to mutations identified in cells of a second patient.... Read more

Tags clinical trials , stem cells , mutations , macular degeneration , blindness , iPSC

2015-04-02

East London genomic study of Asians will shed light on new drugs design

East London genomic study of Asians will shed light on new drugs design

East London Genes and Health project, assuming sequencing genomes of 100 000 Pakistanis and Bangladeshis, has been launched on March 12, 2015. Comparing to people of European ancestry, these ethnic groups more often suffer from various illnesses, mainly heart diseases and type II diabetes. The projec... Read more

Tags mutations , genome sequencing , East London Genes and Health